News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Ryali Sriram
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/25/2023 |
3
| Ryali Sriram (CFO) has filed a Form 3 on CODEXIS, INC. |
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/30/2021 |
4
| Ryali Sriram (CFO) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 30,000 options to buy
@ $8.15, valued at
$244.5k
|
|
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2019 |
4
| Ryali Sriram (CFO) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 149 shares
@ $9.367, valued at
$1.4k
|
|
| 04/22/2019 |
4
| Ryali Sriram (CFO) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Bought 1,250 shares
@ $11.0822, valued at
$13.9k
|
|
| 01/04/2019 |
4
| Ryali Sriram (CFO) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 90,000 options to buy
@ $10.46, valued at
$941.4k
|
|
| 12/27/2018 |
3
| Ryali Sriram (CFO) has filed a Form 3 on Eiger BioPharmaceuticals, Inc. |
|
|